PREVENTION OF MATERNAL AND FETAL COMPLICATIONS IN WOMEN UNDERGOING IN VITRO FERTILIZATION: A COMPREHENSIVE APPROACH
Article Sidebar
Main Article Content
Abstract
In vitro fertilization (IVF) has revolutionized the management of infertility; however, it is accompanied by an increased risk of maternal and fetal complications. These complications include ovarian hyperstimulation syndrome (OHSS), multiple gestations, preterm birth, low birth weight, and placental abnormalities. This prospective, multicenter observational study aimed to evaluate the effectiveness of a comprehensive prevention strategy in reducing such complications among women undergoing IVF. A total of 450 women scheduled for IVF were enrolled and managed using individualized ovarian stimulation protocols, elective single embryo transfer (eSET), intensive monitoring during the luteal phase, and patient-tailored counseling [1]. Maternal and fetal outcomes were compared with historical controls. Our findings demonstrated a significant reduction in the incidence of severe OHSS (from 8.2% to 3.1%, p < 0.01), multiple gestations (from 26.5% to 11.3%, p < 0.001), and preterm deliveries (from 19.4% to 9.8%, p = 0.02) in the intervention group. This study supports the use of an integrated, patient-centered approach in IVF management to prevent complications, thereby improving both maternal and fetal outcomes [2].
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.American Society for Reproductive Medicine (ASRM). (2016). Prevention and Management of Ovarian Hyperstimulation Syndrome. ASRM Committee Opinion.
2.European Society of Human Reproduction and Embryology (ESHRE). (2018). Guidelines on the Prevention of IVF-Related Complications. ESHRE Publications.
3.Humaidan, P., et al. (2010). “Individualized Ovarian Stimulation Protocols in IVF: Rationale and Practical Considerations.” Fertility and Sterility, 93(1), 213–219.
4.Bakhodirovna, M.D. and Taxirovich, A.S., 2024. CHARACTERISTICS OF RHINOVIRUS INFECTION. International journal of medical sciences, 4(08), pp.55-59.
5.Balmasova, I.P., Sepiashvili, R.I. and Malova, E.S., 2016. Molecular Biology Of Hepatitis B Virus And Immunopathogenesis Of Chronic Viral Hepatitis B. Journal of microbiology, epidemiology and immunobiology, 93(2), pp.119-126.
6.Practice Committee of the American Society for Reproductive Medicine. (2013). “Elective Single Embryo Transfer: A Call to Action.” Fertility and Sterility, 100(5), 1239–1245.
7.Fatemi, H. M., & Popovic-Todorovic, B. (2015). “Strategies for Preventing Complications in Assisted Reproductive Technology.” Reproductive Biomedicine Online, 30(6), 621–632.